Clinical trials
Phase 2 trials in Oman
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 2 |
| 2018 | 3 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Cardurion Pharmaceuticals, Inc. | 1 |
| Forma Therapeutics, Inc. | 1 |
| Lakefront Biotherapeutics NV | 1 |
| Modus Therapeutics AB | 1 |
| Novo Nordisk A/S | 1 |
| Oman Medical Speciality Board | 1 |
| Oman Ministry of Health | 1 |
| Sohar Hospital | 1 |
| Sultan Qaboos University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Sickle Cell | 5 |
| Asthma | 2 |
| COVID-19 | 1 |
| Catheter-Related Infections | 1 |
| Hemorrhage | 1 |
| Idiopathic Pulmonary Fibrosis | 1 |
| Iron Overload | 1 |
| Purpura, Thrombocytopenic, Idiopathic | 1 |
| Recurrence | 1 |
Trials
Showing 76 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.